tHEORetically Speaking
Menu Close
  • Home
  • Guest Authors
  • About Us
  • HealthEconomics.Com
  • HE Jobs Portal

covid-19

0

The future of market access: a new model for the ‘next normal’

Posted on October 13, 2021 by Jeff Weisel

The new model of access strategy should build around four key pillars, says Jeff Weisel, Senior Advisor Asia-Pacific, PRMA Consulting. In this update, Jeff explores why the shifting currents of global healthcare are dictating a new approach to market access. Continue Reading →

Guest Bloggers, Market Access, PRMA Consulting biopharma, covid-19, Market Access, PRMA Consulting
0

Getting the most from clinical experts in the time of COVID-19: Lessons learned

Posted on April 5, 2021 by Michael Broder

Gathering experts and soliciting their advice is a time-honored tactic. But methods for doing so invariably involve meeting in person. Although the threat of COVID-19 appears to be slowly receding, business travel may take years to return to pre-crisis levels.… Continue Reading →

COVID-19, PHAR covid-19, PHAR
0

Revealing the Unknown: How the COVID Active Research Experience (CARE) Registry is Enhancing Community Health

Posted on February 24, 2021 by Patti Peeples, R.Ph., Ph.D.

Since COVID-19 first emerged as a global pandemic, the pharmaceutical industry has risen to meet the virus’ related challenges from a prevention as well as a treatment perspective. Continue Reading →

CARE Registry, COVID-19, IQVIA, Nancy Dreyer, pharmaceutical, RWD CARE Registry, covid-19, IQVIA, Nancy Dreyer, RWD
0

COVID-19 and Racial/Ethnic Disparities in Health

Posted on February 4, 2021 by HealthCore Inc.

The COVID-19 pandemic has been characterized by surges in infections in different parts of the country at different times. The most recent rebound of COVID cases, however, indicates that the COVID-19 pandemic is not just a series of isolated surges that is “one and done.” Continue Reading →

COVID-19, HealthCore April Falconi, covid-19, Population Health, Translational Research
0

The 5 Numbers That Will Define Healthcare Value in 2021

Posted on January 11, 2021 by Michael Broder

19. As in COVID. Real world studies of COVID-19’s impact on health care utilization are arriving daily and their continued publication throughout the next year will be the defining characteristic of HEOR in 2021. Continue Reading →

Guest Bloggers, PHAR ACA, affordable care act, coronavirus, covid-19, health care value, ICER, Michael Broder, PHAR, vaccines

Post navigation

Older Articles

About the HealthEconomics.Com Blog:

Insights, observations, executive interviews, critical analysis, and new research for health economics, outcomes research, real-world evidence, and market access community. We welcome guest bloggers.

Check your inbox or spam folder to confirm your subscription.

Recent Posts

  • Podcast Q&A: The Benefits of Linking SDOH with Other Real-World Data
  • How Quality Research Initiatives are Advancing Precision Oncology and Value-Based Care
  • Podcast Q&A: Improving the Representativeness of Research
  • Podcast Q&A: Literature Reviews and Global Value Dossiers

HealthEconomics.Com Twitter Feed

www_healthecon Follow

@ ·
now

Reply on Twitter Retweet on Twitter Like on Twitter Twitter
Load More...

Archives

Visit our website, HealthEconomics.Com, top ranked by Google for news, jobs and resources in healthcare value, market access and more. Read our privacy policy here.
© 2023 tHEORetically Speaking. All rights reserved.
Hiero by aThemes